(Q38880836)

7 September 2017

Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda (English)

1 reference

7 September 2017

0 references

0 references

Plasmodium falciparum

0 references

sulfadoxine

0 references

author name string

Hakim Sendagire

1

1 reference

7 September 2017

Daniel Kyabayinze

2

1 reference

7 September 2017

Göte Swedberg

3

1 reference

7 September 2017

Fred Kironde

4

1 reference

7 September 2017

1 June 2005

1 reference

Tropical Medicine and International Health

7 September 2017

1 reference

7 September 2017

10

1 reference

7 September 2017

6

1 reference

7 September 2017

537-543

1 reference

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

7 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Treatment failure of pyrimethamine‐sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Increasing antimalarial drug resistance in Uganda and revision of the national drug policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Antifolate antimalarial resistance in southeast Africa: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

Sulfadoxine-pyrimethamine monotherapy in Tanzanian children gives rapid parasite clearance but slow fever clearance that is improved by chloroquine in combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01414.X

10.1111/J.1365-3156.2005.01414.X

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference